COVID-19, like most illness caused by other coronaviruses, is mainly a disease of the respiratory system. However, doctors throughout the world have observed that people with high blood pressure or stroke survivors may be more vulnerable to serious complications after COVID-19 diagnosis.
In addition, physicians in highly COVID-19 prevalent locations such as NYC are reporting an increased occurrence of major large artery blockage stroke in otherwise young people without classic stroke risk factors.
Despite these observations and despite effective treatments for acute stroke, alarmingly, many hospitals in the US have seen a significant decrease in the average number of patients presenting to the hospital with stroke signs or symptoms.
Efforts to understand how SARS-coV-2 is connected to high blood pressure and stroke are complicated by a lack of rigorous studies.
However, growing evidence suggests that COVID-19 infection can cause the blood to clot in unusual ways throughout the body and that the virus may also directly induce head or neck artery blocking or narrowing events.
Protecting yourself from exposure to the virus, continuing to take all your medications as prescribed, ensuring that you are eating a healthy diet and getting regular physical activity will help maintain your heart and brain health.
And, of course, it is a good idea to avoid tobacco smoking, vaping, alcohol and recreational drug abuse.
The Center for Disease Control or the World Health Organization (WHO) COVID-19 provide comprehensive up-to-date information regarding safety, symptoms, what do to if someone has been infected, research breakthroughs, travel advice or strategies and plans for reopening the economy.
Meanwhile, JTSSF is steadfast in their commitment to fund and accelerate potentially life-saving stroke research.
JTSSF is a charitable foundation dedicated to preventing stroke and optimizing stroke treatment and recovery.
Founded in 2009 by Dr Jeffrey Thomas, a cerebrovascular neurosurgeon at Washington Hospital in Fremont, CA with special expertise and interest in stroke, Dr Thomas believes that prevention of stroke is among the most important and achievable medical tasks of the 21st century, with tremendous potential for public health impact.
JTSSF is unique in that it focuses on stroke-related research only.
Probi launches new human and pet biotics ranges
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
Avacta reports promising Phase 1a data for faridoxorubicin at ESMO 2025
Jacobio Pharma partners with Oceanpine Capital to focus on core oncology pipeline
Johnson & Johnson to separate its Orthopaedics business as standalone DePuy Synthes
Ascletis selects once-monthly SQ GLP-1R/GIPR dual peptide agonist, ASC35, for clinical development
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio
Amgen offers Repatha through AmgenNow direct-to-patient programme
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
Corstasis and U.S. Heart and Vascular partner to advance heart failure care with ENBUMYST